Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2011

  1. Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sjögren's Syndrome

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 3, pp. 415-423

2009

  1. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

    Journal of Hepatology, Vol. 51, Núm. 6, pp. 1091-1096

2008

  1. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

    Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942

  2. GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: A phase II study

    European Journal of Haematology, Vol. 80, Núm. 2, pp. 127-132

2007

  1. Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma

    Leukemia and Lymphoma, Vol. 48, Núm. 11, pp. 2172-2178

2005

  1. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects

    International Journal of Cardiology, Vol. 98, Núm. 1, pp. 107-112